“ADVERSE PREGNANCY OUTCOMES IN OLIGOHYDRAMNIOS MEASURE BY AMNIOTIC FLUID” (2024) Journal of Population Therapeutics and Clinical Pharmacology, 31(6), pp. 3321–3329. doi:10.53555/hpfq5v13.